SARAH POLACEK: Open Payments
NPI 1336552496 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 13 payments from 7 companies in 2025. Trend: 2023 $195 · 2024 $334 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $133 |
| Smith+Nephew, Inc. | 1 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| LivaNova USA, Inc. | 1 | $29 |
| Amgen Inc. | 1 | $20 |
| ConvaTec Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: DUPIXENT, TULA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, UPLIZNA, INNOVAMATRIX AC, NUCALA.
Industry payments across IN — which companies pay providers there.
